Disorders and Conditions

How many hormones or neurotransmitters do you know? Which are the ones you hear about most frequently? You're probably familiar with dopamine and serotonin....

Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug

Medika Life - February 16, 2022

This article was published orginally in Fortune and is authored by Arthur Allen and republished with permission from KHN (@khnews). The drug industry, patient advocates,...

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston - June 8, 2021

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

18 Million People Now Live With Anorexia or Bulimia, and the Numbers Keep Climbing

DADS GET POSTPARTUM DEPRESSION TOO!

Rage Rooms: Do They Actually Help With Anger?

AI Presents Dangers That Hide With Incredible Ease

LATEST

TRENDING

Gabor Maté’s Bizarre Ideas on Connections Between Stress and Disease

Your Jewish Friends Are Not Alright

From Skinner’s Operant Conditioning to Artificial Intelligence’s Algorithms

Cher’s Severe, Hidden Disorder Chipped Away at Her Self-Esteem

Big Boys Do Cry, and It’s a Normal Reaction, Not Weakness

Were the Billions Invested in Alzheimer’s Research Worthwhile?

How Past Sexual Abuse Can Show Up As (Harm) OCD

FDA Approval of New Drug for Alzheimer’s Offers Hope

How To Spot Sensory “Masking” In Autism Spectrum Disorder

Your Brain Benefits From Walking

EDITORS CHOICE

SUICIDE: IS AI RESPONSIBLE?

The Hormones That Get Too Little Attention and Bring Big Benefits

Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug

FDA Approval of New Drug for Alzheimer’s Offers Hope

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories